HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy (Q35568782)

8 August 2017

HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

Hai-Neng Xu

1

1 reference

8 August 2017

Wei-Dan Huang

2

1 reference

8 August 2017

Ying Cai

3

1 reference

8 August 2017

Miao Ding

4

1 reference

8 August 2017

Jin-Fa Gu

5

1 reference

8 August 2017

Na Wei

6

1 reference

8 August 2017

Lan-Ying Sun

7

1 reference

8 August 2017

Xin Cao

8

1 reference

8 August 2017

Hua-Guang Li

9

1 reference

8 August 2017

Kang-Jian Zhang

10

1 reference

8 August 2017

Xin-Ran Liu

11

1 reference

8 August 2017

Xin-Yuan Liu

12

1 reference

8 August 2017

1 November 2011

1 reference

8 August 2017

1 reference

8 August 2017

10

1 reference

8 August 2017

133

1 reference

https://scigraph.springernature.com/pub.10.1186/1476-4598-10-133

8 August 2017

0 references

cites work

Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Adenovirus-mediated HCCS1 overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Hepatocellular carcinoma: current management and recent advances.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Sp1 and Sp3 regulate basal transcription of the survivin gene

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

A novel E1A-E1B mutant adenovirus induces glioma regression in vivo

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3222618

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

12 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Heat shock phenocopies E1B-55K late functions and selectively sensitizes refractory tumor cells to ONYX-015 oncolytic viral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1476-4598-10-133

Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocellular carcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22040050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22040050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22040050

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-4598-10-133

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference